155 related articles for article (PubMed ID: 26133722)
1. Gradual increase of chronic lymphocytic leukemia incidence in Korea, 1999-2010: comparison to plasma cell myeloma.
Lee SJ; Tien HF; Park HJ; Kim JA; Lee DS
Leuk Lymphoma; 2016; 57(3):585-9. PubMed ID: 26133722
[TBL] [Abstract][Full Text] [Related]
2. Secondary myeloma in patients with chronic lymphoblastic leukemia: A case report and analysis of data from SEER database.
Lin Z; Chen X; Huang Y; Zhao H; Li Z; Xu B
Curr Probl Cancer; 2021 Oct; 45(5):100728. PubMed ID: 33752897
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha promoter polymorphism and the risk of chronic lymphocytic leukemia and myeloma in the Chinese population.
Au WY; Fung A; Wong KF; Chan CH; Liang R
Leuk Lymphoma; 2006 Oct; 47(10):2189-93. PubMed ID: 17071494
[TBL] [Abstract][Full Text] [Related]
4. Incidence rates of chronic lymphocytic leukemia in US states are associated with residential radon levels.
Schwartz GG; Klug MG
Future Oncol; 2016 Jan; 12(2):165-74. PubMed ID: 26515766
[TBL] [Abstract][Full Text] [Related]
5. The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: a distinct increasing trend with birth-cohort effect.
Wu SJ; Huang SY; Lin CT; Lin YJ; Chang CJ; Tien HF
Blood; 2010 Nov; 116(22):4430-5. PubMed ID: 20713960
[TBL] [Abstract][Full Text] [Related]
6. Trends in hematological cancer in the elderly in Denmark, 1980-2012.
Ocias LF; Larsen TS; Vestergaard H; Friis LS; Abildgaard N; Frederiksen H;
Acta Oncol; 2016; 55 Suppl 1():98-107. PubMed ID: 26783877
[TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan.
Tamura K; Sawada H; Izumi Y; Fukuda T; Utsunomiya A; Ikeda S; Uike N; Tsukada J; Kawano F; Shibuya T; Gondo H; Okamura S; Suzumiya J;
Eur J Haematol; 2001 Sep; 67(3):152-7. PubMed ID: 11737247
[TBL] [Abstract][Full Text] [Related]
8. [Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis].
Olafsson GB; Steingrimsdottir H; Vidarsson B; Halldorsdottir AM
Laeknabladid; 2016 Apr; 102(4):171-7. PubMed ID: 27197124
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
10. Leukemia in Iran: Epidemiology and Morphology Trends.
Koohi F; Salehiniya H; Shamlou R; Eslami S; Ghojogh ZM; Kor Y; Rafiemanesh H
Asian Pac J Cancer Prev; 2015; 16(17):7759-63. PubMed ID: 26625794
[TBL] [Abstract][Full Text] [Related]
11. County level incidence rates of chronic lymphocytic leukemia are associated with residential radon levels.
Oancea SC; Rundquist BC; Simon I; Swartz S; Zheng Y; Zhou X; Sens MA; Schwartz GG
Future Oncol; 2017 Sep; 13(21):1873-1881. PubMed ID: 28835109
[TBL] [Abstract][Full Text] [Related]
12. Incidence of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis in Calgary, Alberta, Canada.
Healey R; Patel JL; de Koning L; Naugler C
Leuk Res; 2015 Apr; 39(4):429-34. PubMed ID: 25703352
[TBL] [Abstract][Full Text] [Related]
13. National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953-2012: a systematic analysis of population-based data.
Lenartova A; Johannesen TB; Tjønnfjord GE
Cancer Med; 2016 Dec; 5(12):3588-3595. PubMed ID: 27925456
[TBL] [Abstract][Full Text] [Related]
14. Challenges in assessing the real incidence of chronic lymphocytic leukemia: 16 years of epidemiological data from the province of Girona, Spain.
Solans M; Osca-Gelis G; Comas R; Roncero JM; Gallardo D; Marcos-Gragera R; Saez M
Cancer Causes Control; 2018 Mar; 29(3):379-382. PubMed ID: 29383469
[TBL] [Abstract][Full Text] [Related]
15. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data.
Zent CS; Kyasa MJ; Evans R; Schichman SA
Cancer; 2001 Sep; 92(5):1325-30. PubMed ID: 11571749
[TBL] [Abstract][Full Text] [Related]
16. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
17. Trends in incidence and medical resource utilisation in patients with chronic lymphocytic leukaemia: insights from the UK Clinical Practice Research Datalink (CPRD).
Pfeil AM; Imfeld P; Pettengell R; Jick SS; Szucs TD; Meier CR; Schwenkglenks M
Ann Hematol; 2015 Mar; 94(3):421-9. PubMed ID: 25219890
[TBL] [Abstract][Full Text] [Related]
18. Melanoma in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Famenini S; Martires KJ; Zhou H; Xavier MF; Wu JJ
J Am Acad Dermatol; 2015 Jan; 72(1):78-84. PubMed ID: 25440434
[TBL] [Abstract][Full Text] [Related]
19. The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia.
Diehl LF; Karnell LH; Menck HR
Cancer; 1999 Dec; 86(12):2684-92. PubMed ID: 10594864
[TBL] [Abstract][Full Text] [Related]
20. Improving but inferior survival in patients with chronic lymphocytic leukemia in taiwan: a population-based study, 1990-2004.
Wu SJ; Chiang CJ; Lin CT; Tien HF; Lai MS
PLoS One; 2013; 8(4):e62930. PubMed ID: 23638168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
